Search
- Jan 22
Axsome's CEO on the launches of Auvelity and Sunosi, and the year ahead
Herriot Tabuteau on his company's recent launches, submissions migraine and fibromyalgia, key data in narcolepsy and Alzheimer's, and more.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A